Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1990 Apr;61(4):605–607. doi: 10.1038/bjc.1990.134

Neurone specific enolase (NSE) in small cell lung cancer: a tumour marker of prognostic significance?

M Harding 1, J McAllister 1, G Hulks 1, D Vernon 1, R Monie 1, J Paul 1, S B Kaye 1
PMCID: PMC1971357  PMID: 2158809

Abstract

Pretreatment serum levels of neurone specific enolase (NSE) were measured in patients with small cell lung cancer (SCLC). Median values were significantly higher in patients with extensive compared with limited stage disease (48 ng ml-1 v. 17 ng ml-1: P less than 0.001). Serial NSE levels paralleled the clinical response to treatment. In 37 patients with limited SCLC, receiving identical chemotherapy, the pretreatment NSE level was of prognostic significance: with an approximate reduction in median survival of 10% for each 5 ng ml-1 incremental rise in NSE (P = 0.004).

Full text

PDF
605

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akoun G. M., Scarna H. M., Milleron B. J., Bénichou M. P., Herman D. P. Serum neuron-specific enolase. A marker for disease extent and response to therapy for small-cell lung cancer. Chest. 1985 Jan;87(1):39–43. doi: 10.1378/chest.87.1.39. [DOI] [PubMed] [Google Scholar]
  2. Carney D. N., Marangos P. J., Ihde D. C., Bunn P. A., Jr, Cohen M. H., Minna J. D., Gazdar A. F. Serum neuron-specific enolase: a marker for disease extent and response to therapy of small-cell lung cancer. Lancet. 1982 Mar 13;1(8272):583–585. doi: 10.1016/s0140-6736(82)91748-2. [DOI] [PubMed] [Google Scholar]
  3. Cerny T., Blair V., Anderson H., Bramwell V., Thatcher N. Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patients. Int J Cancer. 1987 Feb 15;39(2):146–149. doi: 10.1002/ijc.2910390204. [DOI] [PubMed] [Google Scholar]
  4. Cooper E. H., Splinter T. A., Brown D. A., Muers M. F., Peake M. D., Pearson S. L. Evaluation of a radioimmunoassay for neuron specific enolase in small cell lung cancer. Br J Cancer. 1985 Sep;52(3):333–338. doi: 10.1038/bjc.1985.198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Esscher T., Steinholtz L., Bergh J., Nöu E., Nilsson K., Påhlman S. Neurone specific enolase: a useful diagnostic serum marker for small cell carcinoma of the lung. Thorax. 1985 Feb;40(2):85–90. doi: 10.1136/thx.40.2.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Johnson D. H., Marangos P. J., Forbes J. T., Hainsworth J. D., Van Welch R., Hande K. R., Greco F. A. Potential utility of serum neuron-specific enolase levels in small cell carcinoma of the lung. Cancer Res. 1984 Nov;44(11):5409–5414. [PubMed] [Google Scholar]
  7. Jørgensen L. G., Osterlind K., Hansen H. H., Cooper E. H. The prognostic influence of serum neuron specific enolase in small cell lung cancer. Br J Cancer. 1988 Dec;58(6):805–807. doi: 10.1038/bjc.1988.313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Osterlind K., Hansen H. H., Hansen M., Dombernowsky P., Andersen P. K. Long-term disease-free survival in small-cell carcinoma of the lung: a study of clinical determinants. J Clin Oncol. 1986 Sep;4(9):1307–1313. doi: 10.1200/JCO.1986.4.9.1307. [DOI] [PubMed] [Google Scholar]
  9. Souhami R. L., Bradbury I., Geddes D. M., Spiro S. G., Harper P. G., Tobias J. S. Prognostic significance of laboratory parameters measured at diagnosis in small cell carcinoma of the lung. Cancer Res. 1985 Jun;45(6):2878–2882. [PubMed] [Google Scholar]
  10. Splinter T. A., Cooper E. H., Kho G. S., Oosterom R., Peake M. D. Neuron-specific enolase as a guide to the treatment of small cell lung cancer. Eur J Cancer Clin Oncol. 1987 Feb;23(2):171–176. doi: 10.1016/0277-5379(87)90011-3. [DOI] [PubMed] [Google Scholar]
  11. Tritz D. B., Doll D. C., Ringenberg Q. S., Anderson S., Madsen R., Perry M. C., Yarbro J. W. Bone marrow involvement in small cell lung cancer. Clinical significance and correlation with routine laboratory variables. Cancer. 1989 Feb 15;63(4):763–766. doi: 10.1002/1097-0142(19890215)63:4<763::aid-cncr2820630426>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  12. Vincent M. D., Ashley S. E., Smith I. E. Prognostic factors in small cell lung cancer: a simple prognostic index is better than conventional staging. Eur J Cancer Clin Oncol. 1987 Nov;23(11):1589–1599. doi: 10.1016/0277-5379(87)90436-6. [DOI] [PubMed] [Google Scholar]
  13. Zelen M. Keynote address on biostatistics and data retrieval. Cancer Chemother Rep 3. 1973 Mar;4(2):31–42. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES